Genitourinary Pathology: Foundations in Diagnostic Pathology, 2E (2014) [PDF] [UnitedVRG]

Genitourinary Pathology: A Volume in the Series: Foundations in Diagnostic Pathology, 2e

by Ming Zhou MD PhD (Author), Cristina Magi-Galluzzi MD PhD (Author)

True PDF, Bookmarked and Indexed

An Original VRG Release





Series: Foundations in Diagnostic Pathology
Hardcover: 720 pages
Publisher: Saunders; 2 edition (January 21, 2015)
Language: English
ISBN-10: 0323188273
ISBN-13: 978-0323188272

Genitourinary Pathology, by Drs. Ming Zhou and Cristina Magi-Galluzzi, a volume in the Foundations in Diagnostic Pathology Series, packs all of today's most essential information on genitourinary pathology into a compact, high-yield format! Well-organized and segmented by type of infectious organism, the book's pragmatic approach complemented by abundant full-color, high-quality photomicrographs and clinical photos, and at-a-glance tables makes it easy to access the information you need to quickly and accurately detect and identify molecular and genetic mechanisms of disease.

"A useful general textbook of GU pathology." Reviewed by: Pathlab.org Date: March 2015

Easily review normal histology before examining abnormal findings so you can avoid false positives.

Gain a superb visual understanding of important histologic features with hundreds of full-color illustrations representing a wide variety of pathologic lesions.

Benefit from the same highly practical format as other titles in this series: consistent headings throughout, summary boxes for pathologic and clinical features, high quality photomicrographs and clinical photos, and a logical organization by type of infectious organism.

Avoid incorrect diagnoses with a separate section on artifacts and pitfalls that highlights common problems you may encounter.

Get up-to-date, comprehensive coverage of the field, including new renal cell carcinoma subtypes and intraductal carcinoma of the prostate; newer immunohistochemical and molecular markers; and updates to the Gleason Grading system for prostate cancer, Fuhrman Grading system for renal cell carcinoma, and TNM classification for GU malignancies.



PLEASE COMMENT AND VOTE